logo-loader

Alliance Pharma plc boss John Dawson discusses transformation since Sinclair acquisition

Published: 23:41 14 Sep 2016 AEST

Alliance Pharma chief executive John Dawson speaks to Proactive Investors’ Stocktube about interim results, released today, which show a business transformed by a major acquisition.
“We took on a business that was the equivalent size of us, so you put the two together and you double your sales and you double your profits,” Dawson says.
“It has given us greater scale.”
Dawson added that as a larger group Alliance is taken more seriously by investors and it is a better candidate for new opportunities.
He also discusses the other highlights for the six month period, looks forward to the remaining months of 2016 and talks future acquisitions.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

6 hours, 46 minutes ago